Jonathan W. Betts
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 2%
- Vibrio bacteria research studies
Papers in
-
- Antibiotic Resistance in Bacteria 21
-
- Infections and bacterial resistance 7
- Enterobacteriaceae and Cronobacter Research 6
- Co-authors
- David W. WarehamRoberto M. La RagioneStephen M. KellyLynette PheeFei ChengMichael HornseyThomas HeinzeJ. Schaller
- Journals
- Journal of Medical Microbiology (4 papers)International Journal of Antimicrobial Agents (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)RSC Advances (2 papers)Journal of Natural Products (2 papers)
- Partner nations
- United KingdomGermanyNetherlands
In The Last Decade
Jonathan W. Betts
42 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 107
- Molecular Medicine 536
- Endocrinology 203
- Applied Microbiology and Biotechnology 42
- Food Science 223
- Pollution 139
Countries citing papers authored by Jonathan W. Betts
This map shows the geographic impact of Jonathan W. Betts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan W. Betts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan W. Betts more than expected).
Fields of papers citing papers by Jonathan W. Betts
This network shows the impact of papers produced by Jonathan W. Betts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan W. Betts. The network helps show where Jonathan W. Betts may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jonathan W. Betts, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2023 | 7 | |
| 3 | 2021 | 18 | |
| 4 | 2020 | 12 | |
| 5 | 2019 | 24 | |
| 6 | 2019 | 29 | |
| 7 | 2018 | 45 | |
| 8 | 2018 | 49 | |
| 9 | 2017 | 99 | |
| 10 | 2017 | 25 | |
| 11 | 2016 | 24 | |
| 12 | 2015 | 3 | |
| 13 | 2015 | 48 | |
| 14 | 2014 | 93 | |
| 15 | 2014 | 29 | |
| 16 | 2014 | 37 | |
| 17 | 2013 | 24 | |
| 18 | SYNERGISTIC ANTIBACTERIAL EFFECTS OF THEAFLAVIN IN COMBINATION WITH AMPICILLIN AGAINST HOSPITAL ISOLATES OF STENOTROPHOMONAS MALTOPHILIA | 2012 | 7 |
| 19 | Minimum inhibitory and bactericidal concentrations of theaflavin and syngergistic combinations with epicatechin and quercetin against clinical isolates of Stenotrophomonas maltophilia | 2012 | 10 |
| 20 | 2011 | 58 |
About Jonathan W. Betts
Jonathan W. Betts is a scholar working on Molecular Medicine, Endocrinology, Applied Microbiology and Biotechnology, Biochemistry and Pollution, having authored 42 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (21 papers), Infections and bacterial resistance (7 papers), Enterobacteriaceae and Cronobacter Research (6 papers), Tea Polyphenols and Effects (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Phytochemicals and Antioxidant Activities (5 papers), Nanoparticles: synthesis and applications (5 papers) and Pharmaceutical and Antibiotic Environmental Impacts (4 papers). The work is most often cited by research in Molecular Medicine (536 citations), Endocrinology (203 citations), Applied Microbiology and Biotechnology (42 citations), Food Science (223 citations) and Pollution (139 citations). Jonathan W. Betts has collaborated with scholars based in United Kingdom, Germany and Netherlands. Frequent co-authors include David W. Wareham, Roberto M. La Ragione, Stephen M. Kelly, Lynette Phee, Fei Cheng, Michael Hornsey, Thomas Heinze, J. Schaller, Neil Woodford and Kozo Fukumoto. Their work appears in journals such as Journal of Medical Microbiology, International Journal of Antimicrobial Agents, Antimicrobial Agents and Chemotherapy, RSC Advances and Journal of Natural Products.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.